https://youtu.be/vtwauNrp8Jo Ben Thrower, MD, Medical Director, Andrew C. Carlos Multiple Sclerosis Institute, talks about different [...]
Lori Saslow, MS; David K.B. Li, MD; June Halper, APN-C; Brenda Banwell, MD; Frederik Barkhof, MD, PhD; Laura Barlow, RTR, RMTR; Kathleen [...]
NeurologyLive®, a multimedia platform dedicated to providing health care professionals who treat neurological diseases with direct access [...]
7Â 5% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease [...]
HERTFORDSHIRE, England, and PITTSBURGH– August 19, 2020 – Mylan N.V. (NASDAQ: MYL) today announced the launch of the first [...]
"The Trump administration's official withdrawal from the World Health Organization (WHO) puts the health of our country at grave risk. As [...]
The US FDA has approved inebilizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults who are anti-aquaporin-4 [...]
